Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy

Authors
Publication date
1 January 2009
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Copenhagen University Research Information System

    redirect
    oaioai:pure.atira.dk:publications...
    Last time updated on 18/12/2019